Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies – Dove Medical Press
|
Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies
Dove Medical Press Abstract: Colorectal cancer is considered a disease of the elderly population. Since the number of geriatric patients continues to rise, monoclonal antibody therapy is the most promising therapy in the recent research. Presently, the monoclonal … |
